Journal of psychopharmacology (Oxford, England)

Keyphrases

Publications

volume 37, number 1, 2023

Jack E Henningfield, Judy Ashworth, David J Heal, Sharon L Smith
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Lester Carhart-Harris, David Luke
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Lester Carhart-Harris, David Luke
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Lester Carhart-Harris, David Luke
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Jack E Henningfield, Judy Ashworth, David J Heal, Sharon L Smith
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Jack E Henningfield, Judy Ashworth, David J Heal, Sharon L Smith
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Lester Carhart-Harris, David Luke
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Jack E Henningfield, Judy Ashworth, David J Heal, Sharon L Smith
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Lester Carhart-Harris, David Luke
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of psychopharmacology (Oxford, England) 37 (1) (2023)

volume 37, number 2, 2023

Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinonen
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Zach V Redding, Karen E Sabol
Reduced attentional lapses in male rats following a combination treatment of low-dose D-serine and atomoxetine. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Ryan K Bachtell, Tracey A Larson, Madeline C Winkler
Adenosine receptor stimulation inhibits methamphetamine-associated cue seeking. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzeel
The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinonen
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Dimy Fluyau, Vasanth Kattalai Kailasam, Christopher G Pierre
A Bayesian meta-analysis of topiramate's effectiveness for individuals with alcohol use disorder. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Ryan K Bachtell, Tracey A Larson, Madeline C Winkler
Adenosine receptor stimulation inhibits methamphetamine-associated cue seeking. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Dimy Fluyau, Vasanth Kattalai Kailasam, Christopher G Pierre
A Bayesian meta-analysis of topiramate's effectiveness for individuals with alcohol use disorder. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzeel
The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinonen
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinonen
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinonen
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Dimy Fluyau, Vasanth Kattalai Kailasam, Christopher G Pierre
A Bayesian meta-analysis of topiramate's effectiveness for individuals with alcohol use disorder. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Zach V Redding, Karen E Sabol
Reduced attentional lapses in male rats following a combination treatment of low-dose D-serine and atomoxetine. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Zach V Redding, Karen E Sabol
Reduced attentional lapses in male rats following a combination treatment of low-dose D-serine and atomoxetine. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinonen
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzeel
The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Ryan K Bachtell, Tracey A Larson, Madeline C Winkler
Adenosine receptor stimulation inhibits methamphetamine-associated cue seeking. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)

volume 37, number 3, 2023

Takesha Cooper, Michael David Seigler, Stephen Stahl
Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions. Journal of psychopharmacology (Oxford, England) 37 (3) (2023)

volume 37, number 5, 2023

Brooke Manning, Amie C Hayley, Sarah Catchlove, Brook Shiferaw, Con Stough, Luke A Downey
Effect of CannEpil ® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Zoé Bollen, Arthur Pabst, Nicolas Masson, Samuel Suárez-Suárez, Carina Carbia, Pierre Maurage
Tell me how you feel, I will tell you what you look at: Impact of mood and craving on alcohol attentional bias in binge drinking. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Brooke Manning, Amie C Hayley, Sarah Catchlove, Brook Shiferaw, Con Stough, Luke A Downey
Effect of CannEpil ® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Brooke Manning, Amie C Hayley, Sarah Catchlove, Brook Shiferaw, Con Stough, Luke A Downey
Effect of CannEpil ® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Marco Battaglia, Cornelius B Groenewald, Fiona Campbell, Simona Scaini, Yves De Koninck, Jennifer Stinson, Patrick D Quinn
We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Marco Battaglia, Cornelius B Groenewald, Fiona Campbell, Simona Scaini, Yves De Koninck, Jennifer Stinson, Patrick D Quinn
We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Brooke Manning, Amie C Hayley, Sarah Catchlove, Brook Shiferaw, Con Stough, Luke A Downey
Effect of CannEpil ® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABA B receptor, and morphine in recreational opioid users. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABA B receptor, and morphine in recreational opioid users. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Marco Battaglia, Cornelius B Groenewald, Fiona Campbell, Simona Scaini, Yves De Koninck, Jennifer Stinson, Patrick D Quinn
We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Zoé Bollen, Arthur Pabst, Nicolas Masson, Samuel Suárez-Suárez, Carina Carbia, Pierre Maurage
Tell me how you feel, I will tell you what you look at: Impact of mood and craving on alcohol attentional bias in binge drinking. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Zoé Bollen, Arthur Pabst, Nicolas Masson, Samuel Suárez-Suárez, Carina Carbia, Pierre Maurage
Tell me how you feel, I will tell you what you look at: Impact of mood and craving on alcohol attentional bias in binge drinking. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABA B receptor, and morphine in recreational opioid users. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)
Brooke Manning, Amie C Hayley, Sarah Catchlove, Brook Shiferaw, Con Stough, Luke A Downey
Effect of CannEpil ® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial. Journal of psychopharmacology (Oxford, England) 37 (5) (2023)

volume 37, number 7, 2023

Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E Michalak, Josh Woolley
Reply to: Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects. Journal of psychopharmacology (Oxford, England) 37 (7) (2023)